By 2050, breast cancer cases and deaths are expected to rise significantly, particularly in countries with low human development index. Researchers using the GLOBOCAN database found disparities in diagnosis and mortality rates globally. Improvements in early diagnosis and treatment, along with investing in high-quality cancer data, are essential to address these growing inequities.

Granules India has acquired Swiss CDMO firm Senn Chemicals AG for CHF 20 million, expanding into the peptide therapeutics segment. The acquisition, expected to complete by mid-2025, aims to leverage Senn's peptide synthesis expertise with Granules' large-scale manufacturing capabilities to deliver high-quality peptide-based solutions globally.

Diabetes is a rising health issue in India, with millions affected by the disease and its precursors. Addressing lifestyle factors such as nutrition, fitness, stress, and sleep is crucial for effective diabetes management and prevention of complications. A holistic approach combining these elements can significantly improve health outcomes.

Since its 2019 launch, eSanjeevani has provided consultations to over 34 crore patients, easing the strain on physical healthcare facilities. Union Health Minister J P Nadda highlighted its role during the Covid pandemic and ongoing free consultations in rural areas. The platform operates in two variants: eSanjeevani AB-AAM and eSanjeevani OPD, offering remote and outpatient services respectively.

Adani Group will invest Rs 6,000 crore to establish two 1,000-bed multi-specialty hospitals and medical colleges in Mumbai and Ahmedabad in collaboration with Mayo Clinic. These integrated health campuses will offer affordable, world-class medical care and education, benefiting people from all socio-economic backgrounds.

The Economic Survey 2024-25 highlighted how drones can address quality, accessibility, and affordability issues in India's healthcare. Projects like Medicines from the Sky and i-DRONE have already demonstrated their potential in a big way, cutting delivery times drastically and improving emergency responses, showcasing their role in saving lives.

Roche Pharma India has announced that Rajwinder Mehdwan will take over as the country general manager from April 1, 2025, replacing V Simpson Emmanuel. Rajji brings over 20 years of healthcare industry experience and has held various leadership roles at Roche and Johnson & Johnson.